Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout.
Saved in:
| Title: | Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout. |
|---|---|
| Authors: | Lipsky PE, Calabrese LH, Kavanaugh A, Sundy JS, Wright D, Wolfson M, Becker MA |
| Source: | Arthritis research & therapy [Arthritis Res Ther] 2014 Mar 04; Vol. 16 (2), pp. R60. Date of Electronic Publication: 2014 Mar 04. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
